New Report Finds Platelet Count Helps Predict Mesothelioma Outcomes, According to Surviving Mesothelioma

Share Article

New research out of China suggests that a simple blood test could be a valuable prognostic tool for patients with malignant pleural mesothelioma.

Simple Mesothelioma Prognostic Tool

High Platelet Count and Mesothelioma Prognosis

High pretreatment platelet count resulted in poor overall survival in malignant mesothelioma.

Scientists at Fujian Medical University in Fujian, China analyzed studies on the relationship between platelet count and mesothelioma survival and found that mesothelioma patients with high pretreatment platelet counts tend to have shorter lifespans. Surviving Mesothelioma has just posted an article on the new study. Click here to read it now.

The newly-published analysis included mesothelioma studies conducted through April 2016 and involved the cases of more than 3,600 mesothelioma patients.

“High pretreatment platelet count resulted in poor overall survival in malignant mesothelioma. Therefore, platelet count could be an adequate and useful factor of prognosis for malignant mesothelioma,” writes Dr. Y. Zhuo, a researcher in Fujian’s Thoracic Surgery Department whose name appears first on the paper.

The analysis, published in the journal Platelets, suggests that platelet count could be a simple way to predict mesothelioma survival and plan for treatment.

“Platelet count is easy, fast, and inexpensive to measure, which could make it a valuable addition to the list of prognostic tests for mesothelioma,” says Alex Strauss, Managing Editor of Surviving Mesothelioma.

To read more about the relationship between platelet count and mesothelioma, see Platelet Count May be an Effective Tool for Mesothelioma Prognosis, now available on the Surviving Mesothelioma website.

Zhuo, Y, et al, “Pretreatment thrombocytosis as a significant prognostic factor in malignant mesothelioma: a meta-analysis”, November 16, 2016, Platelets, Epub ahead of print, https://www.ncbi.nlm.nih.gov/pubmed/27848258

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Ellis
Cancer Monthy
+1 (919) 570-8595
Email >
Follow us on
Visit website